Status and phase
Conditions
Treatments
About
The main purpose of the study is to evaluate the effect of NAL ER on 24-hour cough frequency using objective digital cough monitoring and to assess safety and tolerability of NAL ER.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Other protocol defined inclusion/exclusion criteria may apply.
Primary purpose
Allocation
Interventional model
Masking
165 participants in 4 patient groups, including a placebo group
Loading...
Central trial contact
Catherine Weenink; Beata Dworakowska
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal